ATE83237T1 - Pyridinderivate und verfahren zu ihrer herstellung. - Google Patents

Pyridinderivate und verfahren zu ihrer herstellung.

Info

Publication number
ATE83237T1
ATE83237T1 AT85104723T AT85104723T ATE83237T1 AT E83237 T1 ATE83237 T1 AT E83237T1 AT 85104723 T AT85104723 T AT 85104723T AT 85104723 T AT85104723 T AT 85104723T AT E83237 T1 ATE83237 T1 AT E83237T1
Authority
AT
Austria
Prior art keywords
production
vasodilating
pyride
derivatives
pyride derivatives
Prior art date
Application number
AT85104723T
Other languages
English (en)
Inventor
Kiyoshi Kimura
Iwao Morita
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Application granted granted Critical
Publication of ATE83237T1 publication Critical patent/ATE83237T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657181Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT85104723T 1984-04-19 1985-04-18 Pyridinderivate und verfahren zu ihrer herstellung. ATE83237T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59079560A JPS60248693A (ja) 1984-04-19 1984-04-19 ピリジン誘導体及び製法
EP85104723A EP0159040B1 (de) 1984-04-19 1985-04-18 Pyridinderivate und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE83237T1 true ATE83237T1 (de) 1992-12-15

Family

ID=13693390

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85104723T ATE83237T1 (de) 1984-04-19 1985-04-18 Pyridinderivate und verfahren zu ihrer herstellung.

Country Status (15)

Country Link
US (1) US5036059A (de)
EP (1) EP0159040B1 (de)
JP (1) JPS60248693A (de)
KR (1) KR850007603A (de)
AT (1) ATE83237T1 (de)
AU (1) AU570552B2 (de)
BE (1) BE902210A (de)
DE (1) DE3586879D1 (de)
ES (1) ES8606276A1 (de)
FR (1) FR2563222B1 (de)
GB (1) GB2157695A (de)
IT (1) IT1209945B (de)
NL (1) NL8500909A (de)
SE (1) SE464028B (de)
ZA (1) ZA852591B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6163688A (ja) * 1984-08-03 1986-04-01 Nissan Chem Ind Ltd ジヒドロピリジン−5−ホスホン酸環状エステル類
CN1016063B (zh) 1986-01-22 1992-04-01 日产化学工业株式会社 二氢吡啶-5-膦酸环亚丙基酯的制备
US4885284A (en) * 1986-01-22 1989-12-05 Nissan Chemical Industries Ltd. Dihydropyridine-5-phosphonic acid cyclic propylene ester
JPH0699458B2 (ja) * 1986-01-23 1994-12-07 日産化学工業株式会社 ジヒドロピリジン−5−ホスホン酸環状エステル類
JPS63115890A (ja) * 1986-10-31 1988-05-20 Nippon Shinyaku Co Ltd 2位置換1,4−ジヒドロピリジン誘導体
JPH01275591A (ja) * 1988-04-27 1989-11-06 Nissan Chem Ind Ltd ジヒドロピリジン−5−ホスホン酸誘導体
EP0353692B1 (de) * 1988-08-02 1995-10-04 Nissan Chemical Industries Ltd. Mittel zur Verbesserung von Arzneimitteleffekten für Antitumormittel
JP2850376B2 (ja) * 1988-08-02 1999-01-27 日産化学工業株式会社 抗癌剤薬効増強剤
US20020119201A1 (en) * 2000-09-08 2002-08-29 Novozymes A/S Lubricated granules
WO2004087172A1 (ja) 2003-03-28 2004-10-14 Nissan Chemical Industries Ltd. T型カルシウムチャネル阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2094678A5 (de) * 1970-06-30 1972-02-04 Pepro
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS59161392A (ja) * 1983-03-04 1984-09-12 Nippon Shinyaku Co Ltd ジヒドロピリジン誘導体及びその製法
EP0141222B1 (de) * 1983-09-26 1989-04-12 Nissan Chemical Industries Ltd. Zyklische Dihydropyridin-5-Phosphonsäure-Ester

Also Published As

Publication number Publication date
JPH0259835B2 (de) 1990-12-13
IT1209945B (it) 1989-08-30
GB8507897D0 (en) 1985-05-01
EP0159040A2 (de) 1985-10-23
AU570552B2 (en) 1988-03-17
SE8501882D0 (sv) 1985-04-17
ZA852591B (en) 1986-01-29
NL8500909A (nl) 1985-11-18
JPS60248693A (ja) 1985-12-09
FR2563222A1 (fr) 1985-10-25
EP0159040A3 (en) 1988-08-17
EP0159040B1 (de) 1992-12-09
BE902210A (fr) 1985-10-17
ES8606276A1 (es) 1986-04-01
IT8547862A0 (it) 1985-03-25
KR850007603A (ko) 1985-12-07
SE8501882L (sv) 1985-10-20
US5036059A (en) 1991-07-30
AU4140585A (en) 1985-10-24
FR2563222B1 (fr) 1989-06-09
ES542378A0 (es) 1986-04-01
DE3586879D1 (de) 1993-01-21
SE464028B (sv) 1991-02-25
GB2157695A (en) 1985-10-30

Similar Documents

Publication Publication Date Title
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
ATA912977A (de) Verfahren zur herstellung von neuen in 2-position substituierten 1,4-dihydropyridin- -derivaten und ihren saeureadditionssalzen
ES449162A1 (es) Un procedimiento para la preparacion de un compuesto racemi-co u 8r-antimerico.
DE3888217T2 (de) Supraleitende Zusammensetzungen und Verfahren zu deren Herstellung.
DE3784401D1 (de) Karbostyril-derivate und ihre salze, verfahren zu ihrer herstellung und diese enthaltende kardiotonische zusammensetzung.
ATE83237T1 (de) Pyridinderivate und verfahren zu ihrer herstellung.
DE2967701D1 (de) A-21978 genannte antibiotische mischung, verfahren zu ihrer herstellung, ihre pharmazeutischen zusammensetzungen und produzierender mikroorganismus.
ATE50571T1 (de) Dihydropyridin-carbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
DE3482258D1 (de) 2,2-difluorpropionsaeurederivate und verfahren zu ihrer herstellung.
DE3574706D1 (de) Chartreusin-derivate, ihre salze, antitumorale zusammensetzungen und verfahren zu ihrer herstellung.
FR2347381A1 (fr) Nouveaux derives d'anthracycline-glycosides, en particulier designes sous le nom d'antibiotiques ma 144-m1 et ma 144-m2, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits composes comme agents antitumeurs
ATE37369T1 (de) Eine thiazinverbindung, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3586817T2 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE117307T1 (de) Serinderivate, verfahren zu ihrer herstellung und ihre verwendung in der humantherapie.
ES483201A1 (es) Procedimiento para la obtencion de derivados de acido 1,4- dihidropiridazin-3-carboxilico
ATE24711T1 (de) Bicyclo(3.2.1)octancarbonsaeure-derivate, verfahren zu ihren herstellung und ihre therapeutische verwendung.
ATE103899T1 (de) Zwischenprodukte und verfahren zu ihrer herstellung.
ATA559778A (de) Verfahren zur herstellung von neuen 1,2- -benzisothiazolen und deren saeureadditions- salzen
ATE2520T1 (de) Dihydronicotinsaeurederivate und deren herstellung sowie verwendung.
DE3888697D1 (de) 2,3-thiomorpholinedion-2-oxim-derivate, arzneimittelzusammensetzungen und verfahren zur herstellung.
ATA134577A (de) Verfahren zur herstellung von 9,10- dihydroergosin und dessen physiologisch bertraeglichen saeureadditionssalzen
AT352136B (de) Verfahren zur herstellung von neuen 1,5,10,10a- tetrahydrothiazolo-(3,4-b) -isochinolin-derivaten und von deren saeure- additionssalzen
AT375937B (de) Verfahren zur herstellung von 9-hydrazono-6,7,8, 9-tetrahaydro-4h-pyrido (1,2-a) - pyrimidin-4-on- derivaten sowie von deren physiologisch vertraeglichen salzen, hydraten und isomeren
BE830576A (fr) Derives actifs d'acetoxime, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions
ATE97660T1 (de) Pharmakologisch wirksame 3-substituierte 1,5diaryl-pyrazole und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee